vs
Capstone Holding Corp.(CAPS)与Lakeside Holding Ltd(LSH)财务数据对比。点击上方公司名可切换其他公司
Capstone Holding Corp.的季度营收约是Lakeside Holding Ltd的2.0倍($14.0M vs $7.0M),Capstone Holding Corp.净利率更高(-14.4% vs -22.6%,领先8.2%)
凯普斯通绿色能源公司前身为凯普斯通涡轮公司,1988年注册成立,总部位于美国加利福尼亚州,是一家燃气涡轮制造商,专注于微型涡轮发电以及冷热热电联供系统。该公司产品设计的核心优势是采用空气轴承,可在涡轮全生命周期实现免维护、无液体运行,整机仅含一个运动部件,无需额外冷却或其他辅助系统。
莱克赛德出版社是位于美国芝加哥的出版品牌,由RR唐纳利公司运营。该社除了出版高品质书籍外,还承印邮购目录、电话号码簿、百科全书与广告宣传品,最为人熟知的是为芝加哥卡克斯顿俱乐部出版的高端版本,以及经典重印丛书《莱克赛德经典》。
CAPS vs LSH — 直观对比
营收规模更大
CAPS
是对方的2.0倍
$7.0M
净利率更高
CAPS
高出8.2%
-22.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $14.0M | $7.0M |
| 净利润 | $-2.0M | $-1.6M |
| 毛利率 | 23.3% | 27.2% |
| 营业利润率 | -5.5% | -21.3% |
| 净利率 | -14.4% | -22.6% |
| 营收同比 | — | 95.0% |
| 净利润同比 | — | 18.7% |
| 每股收益(稀释后) | $-0.35 | $-0.08 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CAPS
LSH
| Q4 25 | — | $7.0M | ||
| Q3 25 | $14.0M | $6.1M | ||
| Q2 25 | $13.2M | $6.3M | ||
| Q1 25 | $8.2M | $3.8M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.1M |
净利润
CAPS
LSH
| Q4 25 | — | $-1.6M | ||
| Q3 25 | $-2.0M | $-1.4M | ||
| Q2 25 | $-700.0K | $-893.1K | ||
| Q1 25 | $-1.7M | $-1.1M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | — | $-1.3M |
毛利率
CAPS
LSH
| Q4 25 | — | 27.2% | ||
| Q3 25 | 23.3% | 18.2% | ||
| Q2 25 | 23.7% | 26.7% | ||
| Q1 25 | 16.2% | 18.8% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 12.8% |
营业利润率
CAPS
LSH
| Q4 25 | — | -21.3% | ||
| Q3 25 | -5.5% | -20.8% | ||
| Q2 25 | -2.0% | -8.9% | ||
| Q1 25 | -17.5% | -28.2% | ||
| Q4 24 | — | -55.6% | ||
| Q3 24 | — | -32.5% |
净利率
CAPS
LSH
| Q4 25 | — | -22.6% | ||
| Q3 25 | -14.4% | -22.2% | ||
| Q2 25 | -5.3% | -14.2% | ||
| Q1 25 | -21.2% | -28.2% | ||
| Q4 24 | — | -54.1% | ||
| Q3 24 | — | -32.7% |
每股收益(稀释后)
CAPS
LSH
| Q4 25 | — | $-0.08 | ||
| Q3 25 | $-0.35 | $-0.09 | ||
| Q2 25 | $-0.13 | $-0.11 | ||
| Q1 25 | $-0.47 | $-0.14 | ||
| Q4 24 | — | $-0.26 | ||
| Q3 24 | — | $-0.18 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $730.0K | $1.6M |
| 总债务越低越好 | $11.7M | $2.4M |
| 股东权益账面价值 | $27.2M | $12.2M |
| 总资产 | $58.5M | $24.3M |
| 负债/权益比越低杠杆越低 | 0.43× | 0.20× |
8季度趋势,按日历期对齐
现金及短期投资
CAPS
LSH
| Q4 25 | — | $1.6M | ||
| Q3 25 | $730.0K | $4.5M | ||
| Q2 25 | $773.0K | $5.0M | ||
| Q1 25 | $1.7M | $1.5M | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | — | $2.7M |
总债务
CAPS
LSH
| Q4 25 | — | $2.4M | ||
| Q3 25 | $11.7M | $2.4M | ||
| Q2 25 | $9.6M | $1.4M | ||
| Q1 25 | $8.8M | $774.2K | ||
| Q4 24 | — | $784.8K | ||
| Q3 24 | — | $589.9K |
股东权益
CAPS
LSH
| Q4 25 | — | $12.2M | ||
| Q3 25 | $27.2M | $7.0M | ||
| Q2 25 | $26.3M | $2.8M | ||
| Q1 25 | $27.0M | $749.8K | ||
| Q4 24 | — | $1.6M | ||
| Q3 24 | — | $3.6M |
总资产
CAPS
LSH
| Q4 25 | — | $24.3M | ||
| Q3 25 | $58.5M | $18.6M | ||
| Q2 25 | $51.9M | $14.4M | ||
| Q1 25 | $52.2M | $9.9M | ||
| Q4 24 | — | $9.8M | ||
| Q3 24 | — | $10.8M |
负债/权益比
CAPS
LSH
| Q4 25 | — | 0.20× | ||
| Q3 25 | 0.43× | 0.35× | ||
| Q2 25 | 0.37× | 0.48× | ||
| Q1 25 | 0.33× | 1.03× | ||
| Q4 24 | — | 0.48× | ||
| Q3 24 | — | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $0 | $-453.5K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势,按日历期对齐
经营现金流
CAPS
LSH
| Q4 25 | — | $-453.5K | ||
| Q3 25 | $0 | $-4.0M | ||
| Q2 25 | $-1.7M | $-483.7K | ||
| Q1 25 | $-2.3M | $-238.3K | ||
| Q4 24 | — | $-530.2K | ||
| Q3 24 | — | $-1.4M |
自由现金流
CAPS
LSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-497.4K | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-560.5K | ||
| Q3 24 | — | $-1.4M |
自由现金流率
CAPS
LSH
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -7.9% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -15.6% | ||
| Q3 24 | — | -34.5% |
资本支出强度
CAPS
LSH
| Q4 25 | — | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.0% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 0.1% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPS
| Total Stone | $12.7M | 91% |
| Other | $1.3M | 9% |
LSH
| Transferred Over Time | $4.6M | 65% |
| Distribution Of Pharmaceutical Products | $2.4M | 35% |